Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1

Status

Completed 3Terminated 2Not yet recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Classical hematology 3Lymphoid 1Gastrointestinal 1

Conditions

Anemia 6Colorectal Neoplasms 3Anemia, Iron-Deficiency 3Postoperative Complications 2Neoplasms 2Adenocarcinoma 2Pancreatic Neoplasms 1Lymphoproliferative Disorders 1Inflammatory Breast Neoplasms 1Carcinoma, Ductal, Breast 1

Interventions

ferric carboxymaltose 3iron isomaltoside 1000 1ferroglycine sulfate 1Tomography, X-Ray Computed 1Gastroscopy 1Colonoscopy 1Colonography, Computed Tomographic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Anemia, Iron-Deficiency × ferric carboxymaltose × Clear all
NCT02469480 2020-10-19

Intravenous Ferric Carboxymaltose vs. Oral Iron Substitution in Patients With Metastatic Colorectal Cancer (CRC) and Iron Deficiency Anemia: a Randomized Multicenter Treatment Optimization Study.

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

Phase 2 Completed
64 enrolled
Classical hematologyGastrointestinal

Colorectal Neoplasms, Anemia, Iron-Deficiency

NCT03625661 2018-08-10

CAMARA

Institut Cancerologie de l'Ouest

Phase NA Completed
257 enrolled
Classical hematology

Anemia, Iron-Deficiency

NCT01101399 2013-12-18

FID-CHEMO

Vifor Pharma

Phase 3 Completed
19 enrolled
Classical hematologyLymphoid

Anemia, Lymphoproliferative Disorders, Anemia, Iron-Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡